Cardiol Therapeutics Statistics
NASDAQ: CRDLHealthcareDrug Manufacturers - Specialty & GenericUSD
1.32+0.01 (+0.76%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cardiol Therapeutics by the numbers
Cardiol Therapeutics has a market capitalization of $160.4 million based on 121.51M shares outstanding. With trailing EPS of $-0.25, Cardiol Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.3% below its 50-day average and 2.5% above its 200-day average.
Average daily trading volume is 1.39M shares, or about $1.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CRDL valuation vs. peer median
| Metric | CRDL | Peer median | Difference |
|---|---|---|---|
| Market cap | $160.40M | $175.57M | -9% |
| Avg. volume | 1.39M | 752.09K | +85% |
Peer median across 8 companies: DERM, ORGO, OGI, ADCT, BGM, SIGA, AKBA, LFCR.
Valuation
- Market cap
- $160.40M
- EPS (TTM)
- $-0.25
- Shares outstanding
- 121.51M
Price and trading
- Previous close
- 1.31
- Open
- 1.31
- Day range
- 1.29 – 1.38
- 52-week range
- 0.88 – 2.34
- 52-week change
- +24.53%
- Beta
- —
- Volume
- 3.73M
- Average volume
- 1.39M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 160.40M
- Forward Pe
- -5.74
- Eps
- -0.25
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.34
- Week52 Low
- 0.88
- Avg Volume
- 1.39M
- Shares Outstanding
- 121.51M
- Ma50
- 1.74
- Ma200
- 1.29
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -43.59%
- Pct From52w Low
- 50.00%